Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients.
Alfonso S, Diaz RM, de la Torre A, Santiesteban E, Aguirre F, Pérez K, Rodríguez JL, Barroso Mdel C, Hernández AM, Toledo D, Gabri MR, Alonso DF, Viada C, Gómez RE, Suárez E, Vazquez AM, Perez R, Macias AE. Alfonso S, et al. Among authors: de la torre a. Cancer Biol Ther. 2007 Dec;6(12):1847-52. doi: 10.4161/cbt.6.12.5000. Epub 2007 Sep 8. Cancer Biol Ther. 2007. PMID: 18075301 Free article. Clinical Trial.
A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients.
Alfonso S, Valdés-Zayas A, Santiesteban ER, Flores YI, Areces F, Hernández M, Viada CE, Mendoza IC, Guerra PP, García E, Ortiz RA, de la Torre AV, Cepeda M, Pérez K, Chong E, Hernández AM, Toledo D, González Z, Mazorra Z, Crombet T, Pérez R, Vázquez AM, Macías AE. Alfonso S, et al. Among authors: de la torre av. Clin Cancer Res. 2014 Jul 15;20(14):3660-71. doi: 10.1158/1078-0432.CCR-13-1674. Epub 2014 May 1. Clin Cancer Res. 2014. PMID: 24788102 Clinical Trial.
Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial.
Neninger E, Díaz RM, de la Torre A, Rives R, Díaz A, Saurez G, Gabri MR, Alonso DF, Wilkinson B, Alfonso AM, Combet T, Pérez R, Vázquez AM. Neninger E, et al. Among authors: de la torre a. Cancer Biol Ther. 2007 Feb;6(2):145-50. doi: 10.4161/cbt.6.2.3574. Epub 2007 Feb 5. Cancer Biol Ther. 2007. PMID: 17218777 Free article. Clinical Trial.
Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
García B, Neninger E, de la Torre A, Leonard I, Martínez R, Viada C, González G, Mazorra Z, Lage A, Crombet T. García B, et al. Among authors: de la torre a. Clin Cancer Res. 2008 Feb 1;14(3):840-6. doi: 10.1158/1078-0432.CCR-07-1050. Clin Cancer Res. 2008. PMID: 18245547 Clinical Trial.
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients.
Rodriguez PC, Popa X, Martínez O, Mendoza S, Santiesteban E, Crespo T, Amador RM, Fleytas R, Acosta SC, Otero Y, Romero GN, de la Torre A, Cala M, Arzuaga L, Vello L, Reyes D, Futiel N, Sabates T, Catala M, Flores YI, Garcia B, Viada C, Lorenzo-Luaces P, Marrero MA, Alonso L, Parra J, Aguilera N, Pomares Y, Sierra P, Rodríguez G, Mazorra Z, Lage A, Crombet T, Neninger E. Rodriguez PC, et al. Among authors: de la torre a. Clin Cancer Res. 2016 Aug 1;22(15):3782-90. doi: 10.1158/1078-0432.CCR-15-0855. Epub 2016 Feb 29. Clin Cancer Res. 2016. PMID: 26927662 Clinical Trial.
Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients.
de la Torre A, Pérez K, Vega AM, Santiesteban E, Ruiz R, Hernández L, Durrutí D, Viada CE, Sánchez L, Álvarez M, Durán Y, Moreno YG, Arencibia M, Cepeda M, Domecq M, Cabrera L, Sánchez JL, Hernández JJ, Valls AR, Fernández LE. de la Torre A, et al. Breast Cancer (Auckl). 2016 Feb 18;10:5-11. doi: 10.4137/BCBCR.S32785. eCollection 2016. Breast Cancer (Auckl). 2016. PMID: 26917965 Free PMC article.
Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.
Neninger Vinageras E, de la Torre A, Osorio Rodríguez M, Catalá Ferrer M, Bravo I, Mendoza del Pino M, Abreu Abreu D, Acosta Brooks S, Rives R, del Castillo Carrillo C, González Dueñas M, Viada C, García Verdecia B, Crombet Ramos T, González Marinello G, Lage Dávila A. Neninger Vinageras E, et al. Among authors: de la torre a. J Clin Oncol. 2008 Mar 20;26(9):1452-8. doi: 10.1200/JCO.2007.11.5980. J Clin Oncol. 2008. PMID: 18349395 Clinical Trial.
630 results